Invention Grant
- Patent Title: Gapped oligomeric compounds comprising 5′-modified deoxyribonucleosides in the gap and uses thereof
-
Application No.: US14238094Application Date: 2012-08-08
-
Publication No.: US09752142B2Publication Date: 2017-09-05
- Inventor: Michael Oestergaard , Thazha P. Prakash , Punit P. Seth , Eric E. Swayze
- Applicant: Michael Oestergaard , Thazha P. Prakash , Punit P. Seth , Eric E. Swayze
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- International Application: PCT/US2012/049989 WO 20120808
- International Announcement: WO2013/022967 WO 20130214
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C07H21/04 ; C12N15/113

Abstract:
The present invention provides gapped oligomeric compounds comprising at least one 5′-substituted P-D-2′-deoxyribonucleoside in the gap region. Certain such gapped oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited to, nucleic acids in a cell. The oligomeric compounds provided herein have improved properties such as selectivity, potency and improved proinflammatory profile. In certain embodiments, hybridization results in modulation of the amount of activity or expression of the target nucleic acid in a cell.
Public/Granted literature
- US20140309279A1 GAPPED OLIGOMERIC COMPOUNDS COMPRISING 5'-MODIFIED DEOXYRIBONUCLEOSIDES IN THE GAP AND USES THEREOF Public/Granted day:2014-10-16
Information query
IPC分类: